Mason Street Advisors, LLC Bristol Myers Squibb CO Transaction History

Mason Street Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $18.5 Million - $20.8 Million	-311,727 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $279,634 - $316,877	-4,843 Reduced 1.53%	311,727 $19.3 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $371,055 - $411,178	-6,461 Reduced 2.0%	316,570 $19.1 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $626,592 - $732,548	-11,430 Reduced 3.42%	323,031 $19 Million
Q4 2019 Feb 19, 2020	BUY	$49.21 - $64.19 $4.99 Million - $6.51 Million	101,417 Added 43.52%	334,461 $21.5 Million
Q3 2019 Nov 05, 2019	SELL	$42.77 - $50.71 $10,222 - $12,119	-239 Reduced 0.1%	233,044 $11.8 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $16,063 - $17,762	360 Added 0.15%	233,283 $10.6 Million
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $126,651 - $151,016	2,807 Added 1.22%	232,923 $11.1 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $34,570 - $44,830	709 Added 0.31%	230,116 $12 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $4,249 - $4,793	77 Added 0.03%	229,407 $14.2 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $96,764 - $120,606	1,915 Added 0.84%	229,330 $12.7 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $33,794 - $38,904	-564 Reduced 0.25%	227,415 $14.4 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $19,600 - $21,369	327 Added 0.14%	227,979 $14 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $12.6 Million - $14.5 Million	227,652	227,652 $14.5 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.